Functional differences between influenza A-specific cytotoxic T lymphocyteclones expressing dominant and subdominant TCR

Citation
Tm. Lawson et al., Functional differences between influenza A-specific cytotoxic T lymphocyteclones expressing dominant and subdominant TCR, INT IMMUNOL, 13(11), 2001, pp. 1383-1390
Citations number
37
Categorie Soggetti
Immunology
Journal title
INTERNATIONAL IMMUNOLOGY
ISSN journal
09538178 → ACNP
Volume
13
Issue
11
Year of publication
2001
Pages
1383 - 1390
Database
ISI
SICI code
0953-8178(200111)13:11<1383:FDBIAC>2.0.ZU;2-A
Abstract
We have shown that the dominance of CD8(+) T cells expressing TCR V(beta)17 in the adult HLA-A*0201-restricted influenza A/M1(58-66)-specific response is acquired following first antigen exposure. Despite the acquired dominan ce of V(beta)17(+) cells, subdominant M1(58-66)-Specific clones expressing non-V(beta)17(+) TCR persist in all individuals. To determine whether the a ffinity of the expressed TCR for the HLA-A*0201/M1(58-66) complex could inf luence functional properties, M1(58-66)-specific clones expressing subdomin ant (non-V(beta)17(+)) TCR were compared to cytotoxic T lymphocyte (CTL) cl ones expressing dominant (V(beta)17(+)) TCR. The V(beta)17(+) CTL required up to 10,000-fold lower amounts of M1 peptide to mediate lysis compared to CTL clones expressing other VP gene segments. All V(beta)17(+) CTL clones t ested bound HLA-A*0201/M1(58-66) tetramer, but two of three CTL clones expr essing other TCR did not bind tetramer. The inability of non-V(beta)17(+) C TL to bind tetramer did not correlate with phenotype, CD8 dependence or wit h cytokine production profiles. This suggests a limitation for the use of t etramers in examining subdominant T cell responses. Together these findings suggest that V(beta)17(+) CTL which dominate the HLA-A*0201-restricted CTL response against influenza A are not functionally distinct from subdominan t non-V(beta)17(+) CTL. The dominance of V(beta)17(+) CTL is likely to resu lt from a competitive advantage due to superior CTL avidity for the HLA-A*0 201/M1(58-66) complex.